Jon Kaiser
JonD. Kaiser, MD, is a Clinical Associate at the University of California at San Francisco School of Medicine[1], a past board member of International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[2], previous Medical Director of K-PAX Pharmaceuticals[3], and a physician in private practice specializing in integrative medicine and the treatment of people with diseases of the nervous and immune systems.
Dr. Kaiser personally suffered from ME/CFS for over fifteen years. "It took me five years to recover to the point where I was close to normally functional. If I worked too hard, if some sort of stress occurred that I couldn't avoid, I would have a relapse lasting days to weeks," Kaiser said. "One of the things that got me interested in micronutrients and supplements early on was using them to help support my recovery."[3] I also developed several mind-body techniques that we're extremely helpful in my recovery from ME/CFS.
As Medical Director of K-PAX Pharmaceuticals, Dr. Kaiser helped perform the Synergy Trial, a double-blind, placebo-controlled clinical trial of a new treatment designed to improve the fatigue and decreased concentration symptoms in people with Chronic Fatigue Syndrome (CFS). The treatment combines a low dosage of a prescription stimulant medication, methylphenidate hydrochloride, with broad-spectrum mitochondrial support nutrients.[4]
At the beginning of 2020, Dr. Kaiser returned to private medical practice in Mill Valley, California and currently consults with patients worldwide using telemedicine. In 2019, Dr. Kaiser wrote an E-book titled "A Healing Program for Fibro & Fatigue" that can be obtained free on his medical practice website.
Education
- Bachelor of Science degrees in biochemistry and philosophy from the State University of New York at Binghamton.
- MD, from University of Texas Medical School in Houston, receiving honors in Internal Medicine and Emergency Medicine.[5]
Articles[edit | edit source]
- 2014, Stimulating Energy: Enhancing the Mitochondria in the Synergy Clinical Trial for Chronic Fatigue Syndrome, by Cort Johnson
- 2015, Jon Kaiser, MD: Supporting Mitochondrial Health With Nutrient Therapy
Talks and interviews[edit | edit source]
- 2014, Chronic Fatigue Syndrome (CFS) - Improving Mitochondrial Energy Production
- 2015, Jon Kaiser, MD: Supporting Mitochondrial Health With Nutrient Therapy.[6] (Full transcript of interview)
- 2015, Mitochondrial Medicine and Chronic Fatigue Syndrome
Notable studies[edit | edit source]
- 2015, A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome.[7] (Full Text)
- 2018, KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial[8] (Full Text)
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ USCF directory page for JonD. Kaiser
- ↑ "IACFS/ME homepage".
- ↑ 3.0 3.1 Halstead, Richard (March 22, 2014), "Mill Valley company develops treatment for mysterious chronic fatigue syndrome.", Marin Independent Journal
- ↑ "JonD. Kaiser homepage".
- ↑ "Biography, JonD. Kaiser". WebMD.
- ↑ Kaiser, J; Gustafson, C (July 2015). "Supporting Mitochondrial Health With Nutrient Therapy". Alternative Therapies in Health and Medicine. 21 (Suppl 2): 77-79. PMID 26308764.
- ↑ Kaiser, JD (July 15, 2015). "A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome". International Journal of Clinical and Experimental Medicine. 8 (7): 11064–11074. PMID 26379906.
- ↑ Montoya, Jose G; Anderson, Jill N; Adolphs, Danya L; Bateman, Lucinda; Klimas, Nancy; Levine, Susan M; Garvert, Donn W; Kaiser, Jon D (2018). "KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial" (PDF). International Journal of Clinical and Experimental Medicine. 11 (3): 2890–2900.
